SlideShare una empresa de Scribd logo
1 de 4
Descargar para leer sin conexión
The Patient Recruitment                            Recruitment of Volunteers…
      Challenges                                      Most under-estimated and most crucial part
                                                       of a human clinical study
Can Emerging Regions Help?
                                                      Not planned early enough
     Mukesh Kumar, PhD, RAC                               “All eggs in one basket” syndrome
                                                          Trouble-shooting verses Trouble-Prevention
                 Senior Director
      Regulatory Affairs & Quality Assurance              One size fit all strategies
            Amarex Clinical Research                  Poorly planned
         Germantown, MD 20874, USA                        Recruitment strategies
           mukeshk@amarexcro.com
                                                          Expanding exposure
                240-454-6835
                                                                       www.amarexcro.com                2




Challenges to Recruitment                          Recruitment is Getting Harder
   Lack of patient pools                             Too many trials
   Availability of competing treatments              Few experienced sites and investigators
   Standard of care available                        Good standard of care (in US and
                                                       Western EU)
   Quality of life of patients
                                                      Few truly innovative therapies (wonder
   Length and frequency of treatment
                                                       drugs)
   Public relations and public awareness
                                                      Many high profile failures

                                                           Recruitment strategies are critical
                   www.amarexcro.com           3                       www.amarexcro.com                4




Emerging Regions of the World                      Emerging Regions are Pooled for
                                                   a Reason
Formerly known as the “Third World”
                                                          Similar health-care infrastructure
 BRIC: Brazil, Russia, India and China
                                                          Similar patient pools
 South-East Asia: Korea, Malaysia, etc.
                                                          Similar economic conditions
 Other countries in South America
                                                          Similar history of clinical trials
 Eastern Europe: Poland, Romania,
  Ukraine, Serbia                                         Similar political and business
                                                           environments
 Africa (only for a few indications)
                                                          Similar access to resources


                   www.amarexcro.com           5                       www.amarexcro.com                6
Role of Emerging Regions in                             Role of Emerging Regions in
Meeting Recruitment Goals                               Meeting Recruitment Goals

   Few trials                                          Additional advantages:
                                                         High rate of patient compliance
   Few investigators and sites (but rapidly
    increasing)                                          Patients in dire need for standard

   Relatively limited availability of Western            treatments
    standard of care                                     “Few” regulatory hurdles (case-by-case)

   Large treatment-naïve patient pools                  Business friendly environment
                                                         Future markets



                     www.amarexcro.com              7                         www.amarexcro.com                 8




Common History                                          Perceptions
    Most clinical trials were Government                    Reduced Cost
     funded and supported                                         Per patient cost
        Since at least 25 years                                  Data management
        Mostly at govt. hospitals                                Trial management
        Mostly on collaborative projects with               Reduced Time
         other governments
                                                                  Rapid recruitment
        Few Regulations
                                                                  All indications
    Private-funded research mostly started                  Friendly Regulatory Environment
     in the last 10 years, at most.
                                                                  Easier approval
        Mostly multi-national corporations
                                                                  Faster than US/EU
        Mostly large multi-national CROs
                                                                  Less restrictive than US/EU
        Indigenous CROs with limited experience

                     www.amarexcro.com              9                         www.amarexcro.com                10




Huge Untapped Potential                                 Definite Need for a Recruitment
    Technical
                                                        Strategy
        Physicians and hospitals/clinics                   Based on indication and population
        Ph.D.s, pharmacists, nurses, etc
        Training resources
                                                            Time of initiation of trial
    Resources                                              Plan for regulatory, ethics, GCP and
        People                                              quality issues
    Financial                                              Components of strategy
        For larger trials
        Rapid recruitment                                       No and location of sites
    Language & Culture                                          Personnel requirements
        Language is an issue in most regions                    Advertisements and promotions
        Huge US influence                                       Measures to ensure non-coercive activities
                     www.amarexcro.com             11                         www.amarexcro.com                12
Recruitment Plan                                                 Framework for Message
                                                                         Be honest
   Who is going to recruit, and who are you                                  What you are doing is research
    looking for?                                                              It is experimental or investigational
   What is your message?                                                     There are unknowns
                                                                              There may be risks
   What are your barriers?                                                   There may or may not be benefits
   When to initiate recruiting?                                         Be clear
   Where do you recruit?                                                Be creative and engaging
   How do you recruit?                                                  Clarify scientific jargon
   Evaluate your recruitment efforts                                    Make analogies
                                                                         Assure confidentiality
                                                                         Answer questions
                        www.amarexcro.com                   13                            www.amarexcro.com            14




Training and Quality Management                                  Training and Quality Issues
                                                                    General Issues
   Written plans with version control                                   GCP Compliance
   Collection of feed-back and                                          Ethics: Approvals by valid of IRB/IECs
    documentation of changes                                             Approval from regulatory agencies
   Setting goals and time-lines                                         SOPs and Training Issues
   Getting regulatory, ethical and financial                            Documentation
    approvals before implementing                                   Compliance issues
   Adaptive recruitment                                                 Coercive actions
                                                                         Unapproved processes
                                                                         Undocumented processes

                        www.amarexcro.com                   15                            www.amarexcro.com            16




Customized Recruitment Strategies                                Role of Public Relations
One of the most important component!
                                                                 All our knowledge is the offspring of our
 Build a comprehensive recruitment plan
                                                                    perceptions – Leonardo Da Vinci
       Site qualification
       Investigator qualification                                Role of media in emerging regions
       Advertisement and promotion of trial                             Very vocal, less knowledgeable
       Recruitment camps                                                Short attention span
       Incentives: Site personnel and patients                          Long-term influence
           Within reason and approved by IRB/IEC
   Get plans approved by all applicable IRB/IEC
                                                                    Public perception of foreign sponsor
                                                                         Deep pockets
   Execution of plan
       Training, initiation, communication and follow-up                Extended reach
       Trouble-shooting                                                 Higher demands for quality and compliance
                        www.amarexcro.com                   17                            www.amarexcro.com            18
Future Prospects
   Strong competition among different
    countries                                              Thank You!
   Increased use of English as primary              Questions and Comments
    professional language
   Higher patient awareness                          Mukesh Kumar, PhD, RAC
   Increased cost                                      Senior Director, Regulatory Affairs
                                                            Amarex Clinical Research
   Increased feasibility
                                                         Germantown, MD 20874, USA
   Increased supervision by local regulators                Tel: 001-240-452-6835
    and the FDA                                         Email: mukeshk@amarexcro.com

                  www.amarexcro.com             19

Más contenido relacionado

Destacado

JISC BCE - Dissemination
JISC BCE - DisseminationJISC BCE - Dissemination
JISC BCE - DisseminationJISC BCE
 
JISC BCE Programme Streams
JISC BCE Programme StreamsJISC BCE Programme Streams
JISC BCE Programme StreamsJISC BCE
 
Collision Course: US vs. Europe & International Law
Collision Course: US vs. Europe & International LawCollision Course: US vs. Europe & International Law
Collision Course: US vs. Europe & International Lawpopp_elizabeth
 
Tom Ledwidge Credentials
Tom Ledwidge CredentialsTom Ledwidge Credentials
Tom Ledwidge CredentialsTom Ledwidge
 
The Future Of Blended Learning V3
The Future Of Blended Learning V3The Future Of Blended Learning V3
The Future Of Blended Learning V3Mary Rose
 
Úvod do umelej inteligencie
Úvod do umelej inteligencieÚvod do umelej inteligencie
Úvod do umelej inteligencieJuraj Bednar
 
Would You Like Fries with that Virtual 10 x 10?
Would You Like Fries with that Virtual 10 x 10?Would You Like Fries with that Virtual 10 x 10?
Would You Like Fries with that Virtual 10 x 10?Michelle Bruno
 
Premier Global - Solutions and Values
Premier Global - Solutions and ValuesPremier Global - Solutions and Values
Premier Global - Solutions and Valuespremierglobal
 
Chemistry Jeopardy
Chemistry JeopardyChemistry Jeopardy
Chemistry Jeopardyginaarnold
 
E Biz Cluster Sept 19 M&A
E Biz Cluster Sept 19 M&AE Biz Cluster Sept 19 M&A
E Biz Cluster Sept 19 M&Amwrjh
 
GöNüL Sultan MüBarek SöZlerii
GöNüL Sultan MüBarek SöZleriiGöNüL Sultan MüBarek SöZlerii
GöNüL Sultan MüBarek SöZleriiyelbeyi
 
The Small Company Clinical Study SponsorRoles & Duties Vis-à-vis Liability
The Small Company Clinical Study SponsorRoles & Duties Vis-à-vis LiabilityThe Small Company Clinical Study SponsorRoles & Duties Vis-à-vis Liability
The Small Company Clinical Study SponsorRoles & Duties Vis-à-vis LiabilityMichael Swit
 

Destacado (17)

Tutorial
TutorialTutorial
Tutorial
 
JISC BCE - Dissemination
JISC BCE - DisseminationJISC BCE - Dissemination
JISC BCE - Dissemination
 
JISC BCE Programme Streams
JISC BCE Programme StreamsJISC BCE Programme Streams
JISC BCE Programme Streams
 
Collision Course: US vs. Europe & International Law
Collision Course: US vs. Europe & International LawCollision Course: US vs. Europe & International Law
Collision Course: US vs. Europe & International Law
 
company profile
company profilecompany profile
company profile
 
Tom Ledwidge Credentials
Tom Ledwidge CredentialsTom Ledwidge Credentials
Tom Ledwidge Credentials
 
The Future Of Blended Learning V3
The Future Of Blended Learning V3The Future Of Blended Learning V3
The Future Of Blended Learning V3
 
Am Sa Fug
Am Sa FugAm Sa Fug
Am Sa Fug
 
Úvod do umelej inteligencie
Úvod do umelej inteligencieÚvod do umelej inteligencie
Úvod do umelej inteligencie
 
Would You Like Fries with that Virtual 10 x 10?
Would You Like Fries with that Virtual 10 x 10?Would You Like Fries with that Virtual 10 x 10?
Would You Like Fries with that Virtual 10 x 10?
 
Premier Global - Solutions and Values
Premier Global - Solutions and ValuesPremier Global - Solutions and Values
Premier Global - Solutions and Values
 
Chemistry Jeopardy
Chemistry JeopardyChemistry Jeopardy
Chemistry Jeopardy
 
E Biz Cluster Sept 19 M&A
E Biz Cluster Sept 19 M&AE Biz Cluster Sept 19 M&A
E Biz Cluster Sept 19 M&A
 
GöNüL Sultan MüBarek SöZlerii
GöNüL Sultan MüBarek SöZleriiGöNüL Sultan MüBarek SöZlerii
GöNüL Sultan MüBarek SöZlerii
 
Doc1
Doc1Doc1
Doc1
 
Pp4
Pp4Pp4
Pp4
 
The Small Company Clinical Study SponsorRoles & Duties Vis-à-vis Liability
The Small Company Clinical Study SponsorRoles & Duties Vis-à-vis LiabilityThe Small Company Clinical Study SponsorRoles & Duties Vis-à-vis Liability
The Small Company Clinical Study SponsorRoles & Duties Vis-à-vis Liability
 

Similar a Patient Recruitment In Emerging Regions July 2010

Good Regulators of Pharmaceuticals (GRP) 22 October 2014
Good Regulators of Pharmaceuticals (GRP) 22 October 2014Good Regulators of Pharmaceuticals (GRP) 22 October 2014
Good Regulators of Pharmaceuticals (GRP) 22 October 2014Ajaz Hussain
 
Anthony Presentation DIA Florida Ctd Nov2007
Anthony Presentation DIA Florida Ctd Nov2007Anthony Presentation DIA Florida Ctd Nov2007
Anthony Presentation DIA Florida Ctd Nov2007AKTaylor
 
Dr. Davy Cheng
Dr. Davy ChengDr. Davy Cheng
Dr. Davy Chengichil
 
Applying NLP to Personalized Healthcare - 2021
Applying NLP to Personalized Healthcare - 2021Applying NLP to Personalized Healthcare - 2021
Applying NLP to Personalized Healthcare - 2021David Talby
 
Solving the operational challenges of oncology clinical trials
Solving the operational challenges of oncology clinical trialsSolving the operational challenges of oncology clinical trials
Solving the operational challenges of oncology clinical trialsRoberto Lara
 
Clinical Trials in Emerging Markets
Clinical Trials in Emerging MarketsClinical Trials in Emerging Markets
Clinical Trials in Emerging MarketsArena International
 
A Prescription for Achieving Long-Term EMR Adoption
A Prescription for Achieving Long-Term EMR AdoptionA Prescription for Achieving Long-Term EMR Adoption
A Prescription for Achieving Long-Term EMR Adoptionslvhit
 
DeciBio Perspectives on Pain Points, Unmet Needs, and Disruption in Precision...
DeciBio Perspectives on Pain Points, Unmet Needs, and Disruption in Precision...DeciBio Perspectives on Pain Points, Unmet Needs, and Disruption in Precision...
DeciBio Perspectives on Pain Points, Unmet Needs, and Disruption in Precision...Andrew Aijian
 
Big data, RWE and AI in Clinical Trials made simple
Big data, RWE and AI in Clinical Trials made simpleBig data, RWE and AI in Clinical Trials made simple
Big data, RWE and AI in Clinical Trials made simpleHadas Jacoby
 
Generic non-biological complex drugs DIA CMC Workshop 2017
Generic non-biological complex drugs DIA CMC Workshop 2017Generic non-biological complex drugs DIA CMC Workshop 2017
Generic non-biological complex drugs DIA CMC Workshop 2017Ajaz Hussain
 
Pitfalls and realities of working with Big Data
Pitfalls and realities of working with Big DataPitfalls and realities of working with Big Data
Pitfalls and realities of working with Big DataKarim Keshavjee
 
Regulatory Challenges In Executing Clinical Trials Globally
Regulatory Challenges In Executing Clinical Trials GloballyRegulatory Challenges In Executing Clinical Trials Globally
Regulatory Challenges In Executing Clinical Trials GloballyMichael Swit
 
Cddi Corporate Presentation
Cddi Corporate PresentationCddi Corporate Presentation
Cddi Corporate Presentationitsbernardchan
 
Virtue Of Being Virtual
Virtue Of Being VirtualVirtue Of Being Virtual
Virtue Of Being VirtualMike Tansey
 

Similar a Patient Recruitment In Emerging Regions July 2010 (20)

Good Regulators of Pharmaceuticals (GRP) 22 October 2014
Good Regulators of Pharmaceuticals (GRP) 22 October 2014Good Regulators of Pharmaceuticals (GRP) 22 October 2014
Good Regulators of Pharmaceuticals (GRP) 22 October 2014
 
Anthony Presentation DIA Florida Ctd Nov2007
Anthony Presentation DIA Florida Ctd Nov2007Anthony Presentation DIA Florida Ctd Nov2007
Anthony Presentation DIA Florida Ctd Nov2007
 
Inc Reducing Risk Wp
Inc Reducing Risk WpInc Reducing Risk Wp
Inc Reducing Risk Wp
 
Inc Reducing Risk
Inc Reducing Risk Inc Reducing Risk
Inc Reducing Risk
 
Dr. Davy Cheng
Dr. Davy ChengDr. Davy Cheng
Dr. Davy Cheng
 
Applying NLP to Personalized Healthcare - 2021
Applying NLP to Personalized Healthcare - 2021Applying NLP to Personalized Healthcare - 2021
Applying NLP to Personalized Healthcare - 2021
 
Solving the operational challenges of oncology clinical trials
Solving the operational challenges of oncology clinical trialsSolving the operational challenges of oncology clinical trials
Solving the operational challenges of oncology clinical trials
 
Can scan final 2012 berkeley
Can scan final 2012 berkeleyCan scan final 2012 berkeley
Can scan final 2012 berkeley
 
Clinical Trials in Emerging Markets
Clinical Trials in Emerging MarketsClinical Trials in Emerging Markets
Clinical Trials in Emerging Markets
 
A Prescription for Achieving Long-Term EMR Adoption
A Prescription for Achieving Long-Term EMR AdoptionA Prescription for Achieving Long-Term EMR Adoption
A Prescription for Achieving Long-Term EMR Adoption
 
DeciBio Perspectives on Pain Points, Unmet Needs, and Disruption in Precision...
DeciBio Perspectives on Pain Points, Unmet Needs, and Disruption in Precision...DeciBio Perspectives on Pain Points, Unmet Needs, and Disruption in Precision...
DeciBio Perspectives on Pain Points, Unmet Needs, and Disruption in Precision...
 
Big data, RWE and AI in Clinical Trials made simple
Big data, RWE and AI in Clinical Trials made simpleBig data, RWE and AI in Clinical Trials made simple
Big data, RWE and AI in Clinical Trials made simple
 
Generic non-biological complex drugs DIA CMC Workshop 2017
Generic non-biological complex drugs DIA CMC Workshop 2017Generic non-biological complex drugs DIA CMC Workshop 2017
Generic non-biological complex drugs DIA CMC Workshop 2017
 
Pitfalls and realities of working with Big Data
Pitfalls and realities of working with Big DataPitfalls and realities of working with Big Data
Pitfalls and realities of working with Big Data
 
Regulatory Challenges In Executing Clinical Trials Globally
Regulatory Challenges In Executing Clinical Trials GloballyRegulatory Challenges In Executing Clinical Trials Globally
Regulatory Challenges In Executing Clinical Trials Globally
 
Cr and opportunities by bhumika
Cr and opportunities by bhumikaCr and opportunities by bhumika
Cr and opportunities by bhumika
 
Cddi Corporate Presentation
Cddi Corporate PresentationCddi Corporate Presentation
Cddi Corporate Presentation
 
CTNeT Overview ASCO 2012
CTNeT Overview ASCO 2012CTNeT Overview ASCO 2012
CTNeT Overview ASCO 2012
 
Virtue Of Being Virtual
Virtue Of Being VirtualVirtue Of Being Virtual
Virtue Of Being Virtual
 
Pharma Assets Portal
Pharma Assets PortalPharma Assets Portal
Pharma Assets Portal
 

Patient Recruitment In Emerging Regions July 2010

  • 1. The Patient Recruitment Recruitment of Volunteers… Challenges  Most under-estimated and most crucial part of a human clinical study Can Emerging Regions Help?  Not planned early enough Mukesh Kumar, PhD, RAC  “All eggs in one basket” syndrome  Trouble-shooting verses Trouble-Prevention Senior Director Regulatory Affairs & Quality Assurance  One size fit all strategies Amarex Clinical Research  Poorly planned Germantown, MD 20874, USA  Recruitment strategies mukeshk@amarexcro.com  Expanding exposure 240-454-6835 www.amarexcro.com 2 Challenges to Recruitment Recruitment is Getting Harder  Lack of patient pools  Too many trials  Availability of competing treatments  Few experienced sites and investigators  Standard of care available  Good standard of care (in US and Western EU)  Quality of life of patients  Few truly innovative therapies (wonder  Length and frequency of treatment drugs)  Public relations and public awareness  Many high profile failures Recruitment strategies are critical www.amarexcro.com 3 www.amarexcro.com 4 Emerging Regions of the World Emerging Regions are Pooled for a Reason Formerly known as the “Third World”  Similar health-care infrastructure  BRIC: Brazil, Russia, India and China  Similar patient pools  South-East Asia: Korea, Malaysia, etc.  Similar economic conditions  Other countries in South America  Similar history of clinical trials  Eastern Europe: Poland, Romania, Ukraine, Serbia  Similar political and business environments  Africa (only for a few indications)  Similar access to resources www.amarexcro.com 5 www.amarexcro.com 6
  • 2. Role of Emerging Regions in Role of Emerging Regions in Meeting Recruitment Goals Meeting Recruitment Goals  Few trials Additional advantages:  High rate of patient compliance  Few investigators and sites (but rapidly increasing)  Patients in dire need for standard  Relatively limited availability of Western treatments standard of care  “Few” regulatory hurdles (case-by-case)  Large treatment-naïve patient pools  Business friendly environment  Future markets www.amarexcro.com 7 www.amarexcro.com 8 Common History Perceptions  Most clinical trials were Government  Reduced Cost funded and supported  Per patient cost  Since at least 25 years  Data management  Mostly at govt. hospitals  Trial management  Mostly on collaborative projects with  Reduced Time other governments  Rapid recruitment  Few Regulations  All indications  Private-funded research mostly started  Friendly Regulatory Environment in the last 10 years, at most.  Easier approval  Mostly multi-national corporations  Faster than US/EU  Mostly large multi-national CROs  Less restrictive than US/EU  Indigenous CROs with limited experience www.amarexcro.com 9 www.amarexcro.com 10 Huge Untapped Potential Definite Need for a Recruitment  Technical Strategy  Physicians and hospitals/clinics  Based on indication and population  Ph.D.s, pharmacists, nurses, etc  Training resources  Time of initiation of trial  Resources  Plan for regulatory, ethics, GCP and  People quality issues  Financial  Components of strategy  For larger trials  Rapid recruitment  No and location of sites  Language & Culture  Personnel requirements  Language is an issue in most regions  Advertisements and promotions  Huge US influence  Measures to ensure non-coercive activities www.amarexcro.com 11 www.amarexcro.com 12
  • 3. Recruitment Plan Framework for Message  Be honest  Who is going to recruit, and who are you  What you are doing is research looking for?  It is experimental or investigational  What is your message?  There are unknowns  There may be risks  What are your barriers?  There may or may not be benefits  When to initiate recruiting?  Be clear  Where do you recruit?  Be creative and engaging  How do you recruit?  Clarify scientific jargon  Evaluate your recruitment efforts  Make analogies  Assure confidentiality  Answer questions www.amarexcro.com 13 www.amarexcro.com 14 Training and Quality Management Training and Quality Issues  General Issues  Written plans with version control  GCP Compliance  Collection of feed-back and  Ethics: Approvals by valid of IRB/IECs documentation of changes  Approval from regulatory agencies  Setting goals and time-lines  SOPs and Training Issues  Getting regulatory, ethical and financial  Documentation approvals before implementing  Compliance issues  Adaptive recruitment  Coercive actions  Unapproved processes  Undocumented processes www.amarexcro.com 15 www.amarexcro.com 16 Customized Recruitment Strategies Role of Public Relations One of the most important component! All our knowledge is the offspring of our  Build a comprehensive recruitment plan perceptions – Leonardo Da Vinci  Site qualification  Investigator qualification  Role of media in emerging regions  Advertisement and promotion of trial  Very vocal, less knowledgeable  Recruitment camps  Short attention span  Incentives: Site personnel and patients  Long-term influence  Within reason and approved by IRB/IEC  Get plans approved by all applicable IRB/IEC  Public perception of foreign sponsor  Deep pockets  Execution of plan  Training, initiation, communication and follow-up  Extended reach  Trouble-shooting  Higher demands for quality and compliance www.amarexcro.com 17 www.amarexcro.com 18
  • 4. Future Prospects  Strong competition among different countries Thank You!  Increased use of English as primary Questions and Comments professional language  Higher patient awareness Mukesh Kumar, PhD, RAC  Increased cost Senior Director, Regulatory Affairs Amarex Clinical Research  Increased feasibility Germantown, MD 20874, USA  Increased supervision by local regulators Tel: 001-240-452-6835 and the FDA Email: mukeshk@amarexcro.com www.amarexcro.com 19